Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
thymus nuclear extract
- Development stage
- Unknown
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Oral, Intramuscular, Intravenous, Sublingual
01
Overview
Thymus nuclear extract is a biologic preparation derived from the nuclei of bovine (calf) thymus cells. It is a complex mixture containing various soluble nuclear antigens (SNAs), most notably Sm, nRNP, Ro (SS-A), La (SS-B), Scl-70, and Jo-1. Historically, its primary use has been as a diagnostic reagent in clinical immunology, serving as the substrate for double immunodiffusion (Ouchterlony), ELISA, and hemagglutination assays to detect antinuclear antibodies (ANAs) in patients with systemic autoimmune rheumatic diseases (SARDs) such as systemic lupus erythematosus (SLE), mixed connective tissue disease (MCTD), and polymyositis. Beyond its diagnostic utility, bovine thymus nuclear extract has been investigated in clinical trials (e.g., NCT06795945) to evaluate its safety, tolerability, and potential immunomodulatory effects in healthy adults, suggesting potential applications as a therapeutic agent or dietary supplement for immune system support.
- Other names
- calf thymus nuclear extractCTNECTEbovine thymus nuclear extract
02
Targets
snRNP (Small nuclear ribonucleoprotein complex)Sm (Small nuclear ribonucleoprotein Sm)AGO2 (Argonaute RISC catalytic component 2)aaRS (Aminoacyl-tRNA synthetase family)Sm (Small nuclear ribonucleoprotein Sm complex)
Beyond the preview
Go deeper on thymus nuclear extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on thymus nuclear extract.